D. Thorat

Hypoxia-driven osteopontin contributes to breast tumor growth through modulation of HIF1α-mediated VEGF-dependent angiogenesis

R. Raja, G. Kundu, K. Lohite, 2014, Oncogene.

Semaphorin 3A upregulates FOXO 3a-dependent MelCAM expression leading to attenuation of breast tumor growth and angiogenesis

G. Kundu, K. Lohite, S. Karnik, 2014, Oncogene.

Osteopontin signaling upregulates cyclooxygenase-2 expression in tumor-associated macrophages leading to enhanced angiogenesis and melanoma growth via α9β1 integrin

G. Kundu, G. Soundararajan, R. Raja, 2014, Oncogene.

Osteopontin signaling upregulates cyclooxygenase-2 expression in tumor-associated macrophages leading to enhanced angiogenesis and melanoma growth via α9β1 integrin

G. Kundu, G. Soundararajan, R. Raja, 2014, Oncogene.

Association of osteopontin and cyclooxygenase-2 expression with breast cancer subtypes and their use as potential biomarkers

Suhas D. Doke, G. Kundu, Reeti Behera, 2013, Oncology letters.

Osteopontin as a therapeutic target for cancer

R. Raja, Dhiraj Kumar, G. Kundu, 2014, Expert opinion on therapeutic targets.

Osteopontin: a potentially important therapeutic target in cancer

Mansoor M Ahmed, R. Raja, Dhiraj Kumar, 2011, Expert opinion on therapeutic targets.